Information Library

Case Studies - Central Nervous System (CNS)

To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.

See all

  • Sort by:
  • Most Recent
  • Title

  • Anticipating the Challenge

    March 3, 2010
    Extensive experience and expertise in Alzheimer's Disease accelerated outcomes in multi-country Phase II study.

  • Advancing Innovation

    March 3, 2010
    Prescreening and safety measures simplified a Phase II study of a four-dose vaccine that required multiple rating scales.

  • Alzheimer's Inroads

    March 3, 2010
    A global, multi-site Phase III trial required a large number of patients with a specific number of sites and patients at each site.

  • Global Reach Leads to CNS Recruitment Speed

    March 27, 2009
    Quintiles CRO truly has global reach; A customer wanted to recruit 220 patients within 14 months at 25 US sites. Quintiles decreased enrollment time to just 8 months

  • Parkinson's Disease

    March 27, 2009
    Quintiles provided project management, clinical monitoring, study site coordination, and pharmacovigilance for a multi-center, multi-national, phase III study of a drug for the treatment of Parkinson's disease.

  • Epilepsy

    March 27, 2009
    Quintiles provided clinical monitoring and project management for a randomized, double-blind, parallel-group,placebo and comparator controlled multicenter study of Drug X in patients with epilepsy

  • Alzheimer's Disease

    March 27, 2009
    Quintiles worked with a client to help determine the safety and tolerability of drug x for Alzheimer's patients

Page 1 of 1 (7 results)

Subscribe to Email Based on Your Interests

Set preferences